16, 17 Recent studies suggest that at least 62% of primary invasive breast cancers express GR. 18, 19 A meta-analysis of gene expression from 1,378 early-stage breast cancer patients found that GR expression was associated with significantly shorter relapse-free survival in patients whose tumors did not express ER, regardless of whether the patients were treated with adjuvant chemotherapy or not.
This paper applies ML to data from somatic mutations, copy number alterations, DNA methylation and gene expression from 1,000 cancer cell lines to model drug response of the cell lines and demonstrates the importance of genomic features for prediction.
In vitro transcription assays were performed to demonstrate direct activation of expression from P1882.
As shown in Figure 6B, U0126 and Akti IV increased the NIS expression from 1.1+2.3% to 2.8+3.2% and 6.5+7.2%, respectively, and to 12+7.0% with combination of the two (Figure 6B, upper panel).
However, here we show a dramatic overall increase in the OXPHOS subunit expression from 12 to 24 months.
We obtained gene expression profiling data on estrogen receptor (ESR1) and progesterone receptor (PGR) mRNA expression from 4,111 patients.
During dwarf chicken leg muscle development, miR-203 exhibits transient upregulated expression from E10 E16 but is sharply downregulated after E16.
Peak expression from scAAV8.FIXR338L ranged from 300 to 400% normal human factor IX (hFIX) activity, and long-term expression plateaued above ∼125% normal hFIX activity (Fig. 1B).
By analysis of gene expression from 1,800 breast cancers, a gene expression signature associated with PIK3CA mutation was developed (PIK3CA-GS).
Among the nine genes, TGM3 had the greatest range of mRNA expression (from 0.000 to 35857-fold difference), while PPL had the smallest range (0.0076 to 29.9953-fold difference).
Some find no change in the key enzyme for fatty acid oxidation, carnitine palmitoyltransferase 1 (CPT1) [ 31, 35], while one study observed persistent decreases in CPT1A gene expression from late gestation to weaning [ 37].
